USFDA grants Orphan Drug Designation for Akantior
SIFI is currently evaluating various options for the commercialization of Akantior (polihexanide) globally, including potential out-license agreements outside its core markets
SIFI is currently evaluating various options for the commercialization of Akantior (polihexanide) globally, including potential out-license agreements outside its core markets
OmniActive seeks to improve lives by enhancing nutrition and wellness through science and innovation
Key takeaways of Q3FY22 quarter & conference call highlights
AstraZeneca will hold the registration and manufacture Pulmicort Respules, while Glenmark will commercialize the product in Columbia
Key takeaways of recent quarter & conference call highlights
The FDA grants ODD status to medicines and potential new medicines intended for the treatment, diagnosis or prevention of rare diseases or disorders that affect fewer than 200,000 people in the US
The license agreement grants Dr. Reddy's the exclusive rights to commercialize the proposed biosimilar in select countries in Latin America and Southeast Asia
Premas Biotech is the developer of the technology for the Covid-19 vaccine and a shareholder in Oravax Medical
In Western Europe, about 2% of procedures are done robotically while the majority, approximately 65%, are open surgery
Ectosense’s NightOwl is a leading cloud-connected home sleep apnea test
Subscribe To Our Newsletter & Stay Updated